Mobix Labs Faces Delisting Concerns

TL;DR

MOBX is on the verge of being delisted, major red flag!

AI Summary

Mobix Labs, Inc. filed an 8-K on November 22, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company was formerly known as Chavant Capital Acquisition Corp. and was incorporated in Delaware.

Why It Matters

This filing indicates potential issues with Mobix Labs' compliance with stock exchange listing requirements, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — The company has received a notice of delisting or failure to meet continued listing standards, which poses a significant risk to its stock trading.

Key Numbers

• 001-40621 — SEC File Number (Identifies the company's filing with the SEC.)
• 98-1591717 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Mobix Labs, Inc. (company) — Registrant
• Chavant Capital Acquisition Corp. (company) — Former company name
• Delaware (jurisdiction) — State of incorporation
• November 18, 2024 (date) — Date of earliest event reported
• November 22, 2024 (date) — Filing date

FAQ

Key Financial Figures

• $0.00001 — tered Class A Common Stock, par value $0.00001 per share MOBX Nasdaq Global Market
• $1.00 — ties to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Requi
• $50 million — um Market Value of Listed Securities of $50 million between June 24, 2024 and August 8, 202

Filing Documents

• form8-k.htm (8-K) — 31KB
• 0001493152-24-047473.txt ( ) — 254KB
• mobx-20241118.xsd (EX-101.SCH) — 4KB
• mobx-20241118_def.xml (EX-101.DEF) — 29KB
• mobx-20241118_lab.xml (EX-101.LAB) — 36KB
• mobx-20241118_pre.xml (EX-101.PRE) — 27KB
• form8-k_htm.xml (XML) — 6KB

01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 18, 2024, Mobix Labs, Inc. (the "Company") received a delinquency notification letter (the "Notice") from the Listing Qualifications Staff (the "Staff") of Nasdaq due to the non-compliance with Nasdaq Listing Rule 5450(a)(1) (the "Listing Rule"), which requires listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Requirement"). The notification of noncompliance has no immediate effect on the listing or trading of the Company's common stock. The Company has 180 calendar days, or until May 19, 2024, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the closing bid price of the Company's common stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during this 180-calendar day compliance period. In the event the Company does not regain compliance with the minimum bid price requirement by May 18, 2024, the Company may be eligible for an additional 180-calendar day compliance period if it elects to transfer to The Nasdaq Capital Market to take advantage of the additional compliance period offered on that market. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and would need to provide written notice of its intention to cure the bid price deficiency during the second compliance period by effecting a reverse stock split if necessary. In the event the Company fails to regain compliance or is not permitted to transfer to The Nasdaq Capital Market before the initial compliance period expires, the Company will receive a written notification from Nasdaq that its common stock is subject to delisting. If the Company were to receive such a notificatio

Forward-Looking Statements

Forward-Looking Statements This Form 8-K contains certain "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this Form 8-K are forward-looking statements. Some of these forward-looking statements can be identified by the use of forward-looking words, including "may," "should," "expect," "intend," "will," "anticipate," "believe," "predict," "plan," "targets," "projects," "could," "would," "continue," or the negatives of these terms or variations of them or similar expressions. All forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For example, there can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement or otherwise meet Nasdaq compliance standards, that Nasdaq will grant the Company any relief from delisting as necessary or that the Company can ultimately meet applicable Nasdaq requirements for any such relief. All forward-looking statements are based upon estimates, forecasts and assumptions that, while considered reasonable by the Company and its management, are inherently uncertain and many factors may cause the actual results to differ materially from current expectations which include, but are not limited to the risks and uncertainties set forth under the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" disclosures contained in Mobix Labs' Securities and Exchange Commission ("SEC") filings, including the prospectus filed on August 29, 2024, its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 and any subsequent SEC filings. These filings identify and address other important risks and uncertainties that c

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Mobix Labs, Inc. Date: November 22, 2024 By: /s/ Keyvan Samini Name: Keyvan Samini Title: President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR